Literature DB >> 21098702

Multicenter study of the association between betapapillomavirus infection and cutaneous squamous cell carcinoma.

Jan Nico Bouwes Bavinck1, Rachel E Neale, Damiano Abeni, Sylvie Euvrard, Adele C Green, Catherine A Harwood, Maurits N C de Koning, Luigi Naldi, Ingo Nindl, Michael Pawlita, Herbert Pfister, Charlotte M Proby, Wim G V Quint, Jan ter Schegget, Tim Waterboer, Sönke Weissenborn, Mariet C W Feltkamp.   

Abstract

Human papillomaviruses (betaPV) from the beta genus cannot be classified according to their oncogenicity due to a paucity of information. This study evaluates the association between betaPV infection and cutaneous squamous cell carcinoma in conjunction with measures of UV exposure and susceptibility. We performed case-control studies in the Netherlands, Italy, and Australia, countries with profoundly different UV exposures. The presence of 25 betaPV types in eyebrow hair follicles was determined using a highly sensitive HPV DNA genotyping assay, and antibodies for the 15 most prevalent betaPV types in a total of 689 squamous cell carcinoma cases and 845 controls were detected using multiplex serology. Multivariate logistic regression models were used for case-control comparisons and interaction analyses. BetaPV DNA was detected in eyebrow hairs of more than 90% of all participants. The presence of betaPV DNA was associated with an increased risk of squamous cell carcinoma in the Netherlands (OR = 2.8; 95% CI 1.3-5.8) and Italy (OR = 1.7; 95% CI 0.79-3.6), but not in Australia (OR = 0.91; 95% CI 0.53-1.6). Seropositivity for betaPV in controls ranged between 52% and 67%. A positive antibody response against 4 or more betaPV types was associated with squamous cell carcinoma in Australia (OR = 2.2; 95% CI 1.4-3.3), the Netherlands (OR = 2.0; 95% CI 1.2-3.4) and fair-skinned Italians (OR = 1.6, 95% CI 0.94- 2.7). The association between UV susceptibility and squamous cell carcinoma was stronger in betaPV-seropositive people. These combined data support the hypothesis that betaPV may play a role in the development of cutaneous squamous cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21098702     DOI: 10.1158/0008-5472.CAN-10-0352

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  51 in total

1.  Sunlight exposure and cutaneous human papillomavirus seroreactivity in basal cell and squamous cell carcinomas of the skin.

Authors:  Michelle R Iannacone; Wei Wang; Heather G Stockwell; Kathleen O'Rourke; Anna R Giuliano; Vernon K Sondak; Jane L Messina; Richard G Roetzheim; Basil S Cherpelis; Neil A Fenske; Kristina M Michael; Tim Waterboer; Michael Pawlita; Dana E Rollison
Journal:  J Infect Dis       Date:  2012-06-01       Impact factor: 5.226

2.  Comparative analysis of transforming properties of E6 and E7 from different beta human papillomavirus types.

Authors:  Iris Cornet; Véronique Bouvard; Maria Saveria Campo; Miranda Thomas; Lawrence Banks; Lutz Gissmann; Jérôme Lamartine; Bakary S Sylla; Rosita Accardi; Massimo Tommasino
Journal:  J Virol       Date:  2011-12-14       Impact factor: 5.103

3.  Cancer and HIV infection in referral hospitals from four West African countries.

Authors:  Antoine Jaquet; Michael Odutola; Didier K Ekouevi; Aristophane Tanon; Emmanuel Oga; Jocelyn Akakpo; Manhattan Charurat; Marcel D Zannou; Serge P Eholie; Annie J Sasco; Emmanuel Bissagnene; Clement Adebamowo; Francois Dabis
Journal:  Cancer Epidemiol       Date:  2015-09-12       Impact factor: 2.984

4.  Prevalence of non-HIV cancer risk factors in persons living with HIV/AIDS: a meta-analysis.

Authors:  Lesley S Park; Raúl U Hernández-Ramírez; Michael J Silverberg; Kristina Crothers; Robert Dubrow
Journal:  AIDS       Date:  2016-01       Impact factor: 4.177

Review 5.  Beta genus papillomaviruses and skin cancer.

Authors:  Peter M Howley; Herbert J Pfister
Journal:  Virology       Date:  2015-02-24       Impact factor: 3.616

6.  Viruses in Skin Cancer (VIRUSCAN): Study Design and Baseline Characteristics of a Prospective Clinic-Based Cohort Study.

Authors:  Rossybelle P Amorrortu; Neil A Fenske; Basil S Cherpelis; Laxmi Vijayan; Yayi Zhao; Juliana Balliu; Jane L Messina; Vernon K Sondak; Anna R Giuliano; Tim Waterboer; Michael Pawlita; Tarik Gheit; Massimo Tommasino; Dana E Rollison
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-08-19       Impact factor: 4.254

7.  Cutaneous Viral Infections Across 2 Anatomic Sites Among a Cohort of Patients Undergoing Skin Cancer Screening.

Authors:  Dana E Rollison; Michael J Schell; Neil A Fenske; Basil Cherpelis; Jane L Messina; Anna R Giuliano; Pearlie K Epling-Burnette; Shalaka S Hampras; Rossybelle P Amorrortu; Juliana Balliu; Laxmi Vijayan; Syeda Mahrukh Hussnain Naqvi; Yayi Zhao; Kaustubh Parab; Sandrine McKay-Chopin; Tarik Gheit; Massimo Tommasino
Journal:  J Infect Dis       Date:  2019-02-15       Impact factor: 5.226

Review 8.  An Emerging Issue in Oncogenic Virology: the Role of Beta Human Papillomavirus Types in the Development of Cutaneous Squamous Cell Carcinoma.

Authors:  Dana E Rollison; Daniele Viarisio; Rossybelle P Amorrortu; Tarik Gheit; Massimo Tommasino
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

9.  Cutaneous alpha, beta and gamma human papillomaviruses in relation to squamous cell carcinoma of the skin: a population-based study.

Authors:  Shohreh F Farzan; Tim Waterboer; Jiang Gui; Heather H Nelson; Zhongze Li; Kristina M Michael; Ann E Perry; Steven K Spencer; Eugene Demidenko; Adele C Green; Michael Pawlita; Margaret R Karagas
Journal:  Int J Cancer       Date:  2013-04-22       Impact factor: 7.396

10.  Cutaneous human papillomavirus infection and Basal cell carcinoma of the skin.

Authors:  Mina S Ally; Jean Y Tang; Sarah T Arron
Journal:  J Invest Dermatol       Date:  2013-06       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.